Diabetes mellitus is an important and growing health problem for all countries,
regardless of their degree of development. Diabetes Mellitus is characterized by
increased hyperglycemia, caused by the lack of insulin or its inability to properly
perform its function, leading to metabolic disorders. The main objective of research is
to evaluate the glycemic and metabolic profile of type 1 diabetic patients using a
continuous insulin infusion system (SICI) in a hospital health unit in the Amazon region.
In the State of Pará, it has been implemented since 2019, the Continuous Insulin
Infusion System (SICI) is seen as an alternative to the multiple daily application of
insulin by diabetes patients, although it has numerous advantages, its availability in the
public health system is still very low. Where, this is a retrospective, quantitative study
with a descriptive approach. Regarding the results and discussions, a data collection
was carried out at the diabetes clinic of the Endocrinology service of the Jean Bitar
Hospital/CEDEPA, with a total of 83 patients, 79% of whom were SUS users, 55%
were female, aged 26 years. .5±12.0 years, BMI of 23.0 ±7.2 kg/m² and T1DM
diagnosis time of 13.7±9.2 years. Where they were tabulated and divided according to
response and adaptation to treatment in glycated hemoglobin <7% and >7%. The
present research also has a direct analysis regarding the patients and the main basic
benefits of the use of the Continuous Infusion System of Insulin, where one of them is
the ease of use, giving greater safety to the patient and above all, making the treatment
more flexible. and its membership. Thus, it is concluded that the use of SICI is a great
advance in the treatment of patients with DM, where patients with glycated hemoglobin
<7%, partially obtained a better result in quality of care regarding DM and that SICI has
evidence and direct efficacy with patients of different ages, also resulting in their quality
of life.
|
